Omalizumab in children with inadequately controlled severe allergic (IgE-mediated) asthma

Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years

(2014) C Main et al.   HEALTH TECHNOLOGY ASSESSMENT

Safety and tolerability of omalizumab

(2009) J. Corren et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma

(2009) Bob Lanier et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Global variation in the prevalence and severity of asthma symptoms: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC)

(2009) C K W Lai et al.   THORAX

Severe childhood asthma: a common international approach?

(2008) Andrew Bush et al.   LANCET

Effect of Long-term Corticosteroid Use on Bone Mineral Density in Children: A Prospective Longitudinal Assessment in the Childhood Asthma Management Program (CAMP) Study

(2008) H. W. Kelly et al.   PEDIATRICS

Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: An open-label study

(2008) R. Niven et al.   RESPIRATORY MEDICINE